These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 102466)
21. Metabolism of thyrotropin releasing hormone in brain extracts. Isolation and characterization of an imidopeptidase for histidylprolineamide. Matsui T; Prasad C; Peterkofsky A J Biol Chem; 1979 Apr; 254(7):2439-45. PubMed ID: 107159 [TBL] [Abstract][Full Text] [Related]
22. Enzymatic degradation of thyrotropin releasing hormone by pancreatic homogenates. Failure to detect His-Pro-diketopiperazine as TRH metabolite. Aratan-Spire S; Wolf B; Czernichow P Neuroendocrinology; 1986; 42(5):399-406. PubMed ID: 3084986 [TBL] [Abstract][Full Text] [Related]
23. Aspects of chronic oral treatment with thyrotropin-releasing hormone: the hypothalamic-pituitary-thyroid axis in rats. A study with a pharmacological dose of thyrotropin-releasing hormone. Duntas L; Roussel JP; Astier H; Keck FS; Rosenthal J; Pfeiffer EF Pharmacology; 1991; 43(2):106-12. PubMed ID: 1775509 [TBL] [Abstract][Full Text] [Related]
24. Adenohypophyseal degradation of thyrotropin releasing hormone regulated by thyroid hormones. Bauer K Nature; 1987 Nov 26-Dec 2; 330(6146):375-7. PubMed ID: 3120012 [TBL] [Abstract][Full Text] [Related]
25. Thyrotrophin-releasing hormone inactivation by human postmortem brain. Griffiths EC; Baris C; Visser TJ; Klootwijk W Regul Pept; 1985 Mar; 10(2-3):145-55. PubMed ID: 3922011 [TBL] [Abstract][Full Text] [Related]
26. Delineation of a particulate thyrotropin-releasing hormone-degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase. Friedman TC; Wilk S J Neurochem; 1986 Apr; 46(4):1231-9. PubMed ID: 2869108 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of degradation and measurement of immunoreactive thyrotropin-releasing hormone in rat blood and plasma. Eskay RL; Oliver C; Warberg J; Porter JC Endocrinology; 1976 Feb; 98(2):269-77. PubMed ID: 813988 [TBL] [Abstract][Full Text] [Related]
28. Effects of thyrotropin-releasing hormone and a thyrotropin releasing hormone analog on growth and selected plasma hormones in lambs. Muir LA; Wien S J Anim Sci; 1983 Jul; 57(1):139-45. PubMed ID: 6411671 [TBL] [Abstract][Full Text] [Related]
29. Release of thyrotropin and prolactin by a thyrotropin-releasing hormone (TRH) precursor, TRH-Gly: conversion to TRH is sufficient for in vivo effects. Pekary AE; Stephens R; Simard M; Pang XP; Smith V; DiStefano JJ; Hershman JM Neuroendocrinology; 1990 Dec; 52(6):618-25. PubMed ID: 2126612 [TBL] [Abstract][Full Text] [Related]
30. Effect of chronic treatment with thyrotropin-releasing hormone (TRH) or an analog of TRH (linear beta-alanine TRH) on the hypothalamic-pituitary-thyroid axis. Nemeroff CB; Bissette G; Martin JB; Brazeau P; Vale W; Kizer JS; Prange AJ Neuroendocrinology; 1980 Apr; 30(4):193-9. PubMed ID: 6769064 [TBL] [Abstract][Full Text] [Related]
31. Ontogeny of thyrotropin releasing hormone and precursor peptide in the rat. Fuse Y; Polk DH; Lam RW; Fisher DA Pediatr Res; 1991 Jul; 30(1):28-33. PubMed ID: 1909780 [TBL] [Abstract][Full Text] [Related]
32. Identification of Asn289 as a ligand binding site in the rat thyrotropin-releasing hormone (THR) receptor as determined by complementary modifications in the ligand and receptor: a new model for THR binding. Han B; Tashjian AH Biochemistry; 1995 Oct; 34(41):13412-22. PubMed ID: 7577928 [TBL] [Abstract][Full Text] [Related]
33. Effects of anti-thyrotropin-releasing hormone anti-serum treatment during the neonatal period on the development of rat thyroid function. Mitsuma T; Nogimori T Horm Metab Res; 1984 Aug; 16(8):428-30. PubMed ID: 6432670 [TBL] [Abstract][Full Text] [Related]
34. Evidence for interplay between thyrotropin-releasing hormone (TRH) and its structural analogue pGlu-Glu-Pro-NH2 ([Glu2]TRH) in the brain: an in vivo microdialysis study. Nguyen V; Zharikova AD; Prokai L Neurosci Lett; 2007 Mar; 415(1):64-7. PubMed ID: 17234338 [TBL] [Abstract][Full Text] [Related]
35. Characterization of neutral TRH-like peptides in mammary gland, mammary tumors and milk. Ghilchik MW; Tobaruela M; del Rio-Garcia J; Smyth DG Biochim Biophys Acta; 2000 Jun; 1475(1):55-60. PubMed ID: 10806338 [TBL] [Abstract][Full Text] [Related]
36. The thyrotropin-releasing hormone-like peptides pGlu-Phe-Pro amide and pGlu-Glu-Pro amide increase plasma triiodothyronine levels in the mouse; the activity is sensitive to testosterone. Cremades A; Peñafiel R; Rausell V; Del Rio-Garcia J; Smyth DG Eur J Pharmacol; 1998 Sep; 358(1):63-7. PubMed ID: 9809870 [TBL] [Abstract][Full Text] [Related]
37. Thyrotropin-releasing hormone-like bioactivity in placenta: evidence for the existence of substances other than Pyroglu-His-Pro-NH2 (TRH) capable of stimulating pituitary thyrotropin release. Youngblood WW; Humm J; Lipton MA; Kizer JS Endocrinology; 1980 Feb; 106(2):541-6. PubMed ID: 6766383 [TBL] [Abstract][Full Text] [Related]
38. TRH analogue with C-terminal thioamide group: rapid degradation by plasma and its biological effects. Angyal R; Strbák V; Alexandrová M; Kruszyński M Endocrinol Exp; 1985 Dec; 19(4):213-9. PubMed ID: 3002750 [TBL] [Abstract][Full Text] [Related]